Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 18, 2018 - Issue 6
Submit an article Journal homepage
401
Views
15
CrossRef citations to date
0
Altmetric
Review

Adherence and resource use among psoriasis patients treated with biologics

Joseph S. AleshakiCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
,
Leah A. CardwellCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
,
Mikél E. MuseCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
&
Steven R. FeldmanCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA;Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA;Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-0090-6289View further author information
ORCID Icon
Pages 609-617 | Received 04 Dec 2017, Accepted 13 Aug 2018, Published online: 10 Sep 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kerasia-Maria Plachouri & Sophia Georgiou. (2019) Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis. Journal of Dermatological Treatment 30:7, pages 668-673.
Read now

Articles from other publishers (14)

Deblina DanNimisha Srivastava. (2023) Psoriasis: Striving for Potential Biomarkers. ASSAY and Drug Development Technologies.
Crossref
Laura Pina Vegas, Léa Hoisnard, Léa Bastard, Emilie Sbidian & Pascal Claudepierre. (2022) Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS). RMD Open 8:2, pages e002681.
Crossref
Anastasia Drakos & Ronald Vender. (2022) A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians. Dermatology and Therapy 12:12, pages 2715-2730.
Crossref
Laura Pina Vegas, Laetitia Penso, Pascal Claudepierre & Emilie Sbidian. (2022) Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database. JAMA Dermatology 158:5, pages 513.
Crossref
Laura Pina Vegas, Philippe Le Corvoisier, Laetitia Penso, Muriel Paul, Emilie Sbidian & Pascal Claudepierre. (2022) Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study. Rheumatology 61:4, pages 1589-1599.
Crossref
Eugenia Piragine, Davide Petri, Alma Martelli, Agata Janowska, Valentina Dini, Marco Romanelli, Vincenzo Calderone & Ersilia Lucenteforte. (2022) Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis. Journal of Clinical Medicine 11:6, pages 1506.
Crossref
Laetitia Penso, Christina Bergqvist, Antoine Meyer, Philippe Herlemont, Alain Weill, Mahmoud Zureik, Rosemary Dray‐Spira & Emilie Sbidian. (2022) Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin‐17 Inhibitors: A Nationwide Population‐Based Study Using the French National Health Data System . Arthritis & Rheumatology 74:2, pages 244-252.
Crossref
Ilteris Oguz Topal, Asude Kara Polat, İlkin Zindancı, İlknur Kıvanç Altunay, Tuğba Özkök Akbulut, Eylem Emel Arıkan, Filiz Topaloğlu Demir, Onur Sivaz & Ayşe Serap Karadağ. (2021) Adherence to systemic therapy in patients with psoriasis during the COVID‐19 pandemic: A multicenter study. Journal of Cosmetic Dermatology 21:1, pages 39-47.
Crossref
Jonathan I. Silverberg, Eric L. Simpson, April W. Armstrong, Marjolein S. de Bruin-Weller, Alan D. Irvine & Kristian Reich. (2021) Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis. American Journal of Clinical Dermatology 23:1, pages 1-11.
Crossref
Qisi Sun, Patrick O. Perche, Varun K. Ranpariya & Steven R. Feldman. 2022. Biologic Therapy for Psoriasis. Biologic Therapy for Psoriasis 131 141 .
Luisa Martos-Cabrera, Alberto Calvo-Garcia, Beatriz Butron-Bris, Ana Reymundo, C. Santamaria, Enrique Ovejero-Merino, Esteban Dauden-Tello, Esther Ramirez- Herraiz & Mar Llamas-Velasco. (2021) Intense Impact of Health Alert Due to COVID-19 on Adherence of Moderate to Severe Psoriasis Patients to Hospital Therapy. Journal of Skin and Stem Cell 8:2.
Crossref
Armaan Guraya, Uros Rakita, Caroline L. Porter & Steven R. Feldman. (2021) A narrative review of systematic reviews on adherence to psoriasis treatments. Dermatological Reviews 2:5, pages 251-261.
Crossref
Laetitia Penso, Rosemary Dray-Spira, Alain Weill, Laura Pina Vegas, Mahmoud Zureik & Emilie Sbidian. (2021) Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis. JAMA Dermatology 157:9, pages 1056.
Crossref
Yukie Yamaguchi, Yasumasa Kanai, Hiroki Kitabayashi, Hiroki Okada & Hidemi Nakagawa. (2020) Relationship between serum trough levels and efficacy of brodalumab from a post hoc exploratory analysis of a Japanese study in patients with plaque psoriasis . The Journal of Dermatology 48:3, pages 324-333.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.